Back to Connor, Clark & Lunn Investment Management Ltd. Connor, Clark & Lunn Investment Management Ltd.

PLRXPLRX
Showing 6 of 8 quarters

Position history for Connor, Clark & Lunn Investment Management Ltd.Connor, Clark & Lunn Investment Management Ltd.'s holdings in PLIANT THERAPEUTICS INC

Connor, Clark & Lunn Investment Management Ltd. holds 536,081 shares of PLRX (PLIANT THERAPEUTICS INC), worth $611,132 as of 2026-Q2. The position was increased (+3.6% shares). PLRX represents 0.0% of Connor, Clark & Lunn Investment Management Ltd.'s portfolio.

Current Value

$611,132

Current Shares

536,081

Total Value Change

+$223,143

Total Shares Change

+501,470

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
536,081
+3.6%
$611,1320.0%$1.14
25
2026-Q1
Increased
517,453
+39.1%
$651,9910.0%$1.25
32
2025-Q4
Increased
371,951
+1428.2%
$453,7800.0%$1.21
39
2025-Q3
New
24,340
-
$36,0230.0%$1.49
28
2024-Q4
Exited
0
-100.0%
$00.0%$12.79
0
2024-Q3
New
34,611
-
$387,9890.0%$11.31
33

Other major holders of PLRX: BlackRock Finance, Inc., PRICE T ROWE ASSOCIATES INC /MD/, BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used